Barriers to treatment access for chronic hepatitis C virus infection: A case series

Alexander J. Millman; Boatemaa Ntiri-Reid; Risha Irvin; Maggie H. Kaufmann; Andrew Aronsohn; Jeffrey S. Duchin; John D. Scott; Claudia Vellozzi

Barriers to treatment access for chronic hepatitis C virus infection: A case series

Alexander J. Millman, Boatemaa Ntiri-Reid, Risha Irvin, Maggie H. Kaufmann, Andrew Aronsohn, Jeffrey S. Duchin, John D. Scott, Claudia Vellozzi

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.

Original language	English (US)
Pages (from-to)	110-113
Number of pages	4
Journal	Topics in antiviral medicine
Volume	25
Issue number	3
State	Published - 2017

Keywords

HCV
Hepatitis C virus
Insurance
Treatment

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases
Virology

Access to Document

Fingerprint Dive into the research topics of 'Barriers to treatment access for chronic hepatitis C virus infection: A case series'. Together they form a unique fingerprint.

Cite this

Barriers to treatment access for chronic hepatitis C virus infection : A case series. / Millman, Alexander J.; Ntiri-Reid, Boatemaa; Irvin, Risha; Kaufmann, Maggie H.; Aronsohn, Andrew; Duchin, Jeffrey S.; Scott, John D.; Vellozzi, Claudia.

In: Topics in antiviral medicine, Vol. 25, No. 3, 2017, p. 110-113.

Research output: Contribution to journal › Article › peer-review

@article{638183d016ea4ae69400699d322ef608,

title = "Barriers to treatment access for chronic hepatitis C virus infection: A case series",

abstract = "Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.",

keywords = "HCV, Hepatitis C virus, Insurance, Treatment",

author = "Millman, {Alexander J.} and Boatemaa Ntiri-Reid and Risha Irvin and Kaufmann, {Maggie H.} and Andrew Aronsohn and Duchin, {Jeffrey S.} and Scott, {John D.} and Claudia Vellozzi",

year = "2017",

language = "English (US)",

volume = "25",

pages = "110--113",

journal = "Topics in antiviral medicine",

issn = "2161-5853",

publisher = "International Antiviral Society",

number = "3",

}

TY - JOUR

T1 - Barriers to treatment access for chronic hepatitis C virus infection

T2 - A case series

AU - Millman, Alexander J.

AU - Ntiri-Reid, Boatemaa

AU - Irvin, Risha

AU - Kaufmann, Maggie H.

AU - Aronsohn, Andrew

AU - Duchin, Jeffrey S.

AU - Scott, John D.

AU - Vellozzi, Claudia

PY - 2017

Y1 - 2017

N2 - Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.

AB - Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.

KW - HCV

KW - Hepatitis C virus

KW - Insurance

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85027685091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027685091&partnerID=8YFLogxK

M3 - Article

C2 - 28820726

AN - SCOPUS:85027685091

VL - 25

SP - 110

EP - 113

JO - Topics in antiviral medicine

JF - Topics in antiviral medicine

SN - 2161-5853

IS - 3

ER -